MMR vs SBA vs FBD MMR vs 4ANC vs 2PPV MMR vs CPR

MMR SBA FBD MMR 4ANC 2PPV MMR CPR

CY 2011 2011 2011
CY 2012 2012 2012
CY 2013 2013 2013
CY 2014 2014 2014
CY 2015 0 2015 2015
CY 2016 0 2016 2016
CY 2017 2 2017 2017
CY 2018 0 \ 2018 2018

4ANC vs TT2 Plus vs IFA Livebirths vs BCG MCP-Accredited HFs vs FBD

4ANC TT2 Plus IFA Livebirths BCG MCP HF FBD
2011 2016 2016
2012 2017 2017
2013 2018 2018
2014
2015
2016
2017
2018
 CPR per Commodity 4ANC vs 2PPV vs IFA 2 PPV vs Hepa B
2016 2017 2018 4ANC 2PPV IFA 2 PPV Hepa B
Female
Ster./BTL 6 5 4.4 2011 2016
Male
Ster/Vasect
omy 0.2 0.2 0.2 2012 2017
Pills 64 43.19 47.82 2013 2018
IUD 9 5.9 6.35 2014
Injectables 9 5.88 83.54 2015 42 ggr
NFP All
Methods 2016 35
Condom 2017 33
Implants 2018 33

FBD vs Hepa B
FBD Livebirths NBS Hepa B BCG
2016
2017
2018
Indicator Target Accomplishment Achieved Trend DESCRIPTIVE FINDINGS
MMR 70 0 Yes increasing
IMR 17 7.24% Yes increasing
U5MR 25 14.49% Yes increasing
SBA 90% 84% No decreasing
FBD 90% 78% No decreasing
4ANC 90% 33% No decreasing
2PPV 90% 42% No decreasing IMPLICATIONS

TT2+ 80% 42% No decreasing

IFA Pregnant 90% 28% No decreasing
CPR 65% 72% No decreasing
FIC 95% 55%% No decreasing
VAC
6-11 mo 90% 68% No decreasing
12-59 mo 90% 82%% No decreasing
EBF 50% 46%% No decreasing
IBF 90% 48%% No decreasing
 No. of MCP Accredited HF and % FBD
12 12
10 10
8 8
Axis Title

6 6
4 4
2 2
- 0
2016 2017 2018

DESCRIPTIVE FINDINGS

IMPLICATIONS
 DESCRIPTIVE FINDINGS
MMR vs CPR
12
10
IMPLICATIONS
8
Axis Title

6
4
2
0
2011 2012 2013 2014 2015 2016 2017 2018
 CU - per commodity (2015-2017)
160

140

120

100

80

60

40

20

0
2016 2017 2018
DESCRIPTIVE FINDINGS

IMPLICATIONS
 2.5 MMR vs FBD
2
Axis Title

1.5
1
0.5
0
CY 2011 CY 2012 CY 2013 CY 2014 CY 2015 CY 2016 CY 2017 CY 2018
DESCRIPTIVE FINDINGS

IMPLICATIONS

z
 MMR vs 4ANC vs 2PPV
12

10

0
2011 2012 2013 2014 2015 2016 2017 2018
Descriptive Analysis

Implication
 4ANC vs TT2 vs IFA
12
10
8
6
4
2
0
2011 2012 2013 2014 2015 2016 2017 2018
Description

Implication
 FBD vs LB vs NBS vs Hepa B vs BCG
12
10
8
6
4
2
0
2016 2017 2018

Description

Implication
DESCRIPTIVE FINDINGS IMPLICATIONS
b
 MMR vs SBA vs FBD MMR vs 4ANC vs 2PPV MMR vs CPR
MMR SBA FBD MMR 4ANC 2PPV MMR CPR
CY 2010 2010 2010
CY 2011 2011 2011
CY 2012 2012 2012
CY 2013 2013 2013
CY 2014 2014 2014
CY 2015 2015 2015
CY 2016 2016 2016
CY 2017 2017 2017
CY 2018 2018 2018

4ANC vs TT2 Plus vs IFA Livebirths vs BCG MCP-Accredited HFs vs FBD

4ANC TT2 Plus IFA Livebirths BCG MCP HF FBD No. of MD
2010 2015 2015
2011 2016 2016
2012 2017 2017
2013 2018 2018
2014
2015 Indicator Target Accomplis Achieved 1. Maternal Mortality Ratio and Number of maternal deaths
2016 MMR 70 65.42 Yes 2. Under five mortality and its absolute number
2017 SBA 90% 94% Yes
2018 FBD 90% 94% Yes
4ANC 90% 42% No 6. VAC supplementation ( in percentage)
2PPV 90% 50% No 7. CPR ( in percentage)
TT2+ 80% 42% No 8. EBF ( in percentage)
IFA Pregnant 43%
 CPR per Commodity 4ANC vs 2PPV vs IFA 2 PPV vs Hepa B
2015 2016 2017 4ANC 2PPV IFA 2 PPV Hepa B
Female 0
Ster./BTL 6% 5% 4.40% 2010 2015 47.60%
Male
Ster/Vase 0
ctomy 0.20% 0.20% 0.20% 2011 2016 57%
Pills 64% 43.19% 47.82% 2012 2017 48% 0
IUD 9% 5.92% 6.35% 2013 2018 43% 22%
Injectable
s 9 5.88% 7.83% 2014
NFP All
Methods 7.40% 15.29% 15.29% 2015 42% 55% 1
Condom 0.98% 1.13% 1.45% 2016 35% 48% 1
Implants 0 0.37% 2.17% 2017 33% 57% 1
2018 33% 42% 48%
FBD vs Hepa B
FBD Livebirths NBS Hepa B BCG
2015 301 406 286 309 557
2016 248 293 272 310 430
2017 290 350 274 281 340
2018 217 276 219 233 281